INND 0.00 Stock Price InnerScope Hearing Technologies, Inc.
Range: | 0.06-1.5 | Vol Avg: | 100458 | Last Div: | 0 | Changes: | 0 |
Beta: | 28.91 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
Sector: | Healthcare | IPO: | Wed Mar 15 2017 | Empoloyees: | 26 |
CUSIP: | 45781P104 | CIK: | 0001609139 | ISIN: | US45781P1049 | Country: | US |
CEO: | Mr. Matthew Ross Moore | Website: | https://www.innd.com |
InnerScope Hearing Technologies, Inc. provides hearing aids and its hearable, and wearable personal sound amplifier products to retail hearing aid dispensing community. The company engages in the provision of manufacturing and direct-to-consumer distribution/retail of hearing aids, personal sound amplifier products, hearing related treatment therapies, doctor-formulated dietary hearing supplements, and proprietary CDB oil for treating tinnitus. It also owns and operates 11 audiological and retail hearing device clinics; and offers business to business SaaS based patient management system software program. The company was formerly known as Innerscope Advertising Agency, Inc. and changed its name to InnerScope Hearing Technologies, Inc. in August 2017. InnerScope Hearing Technologies, Inc. was incorporated in 2012 and is headquartered in Roseville, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.